Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06733428 · ClinicalTrials.gov registry record

Agreement and Precision Study

A clinical trial, sponsored by Topcon Corporation.

Completed
Registry status
108
Enrollment target

NCT06733428: Completed study, sponsored by Topcon Corporation.

NCT06733428 is a clinical trial that has completed, run by Topcon Corporation. The registered enrollment target is 108 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06733428 has completed, sponsored by Topcon Corporation.

COMPLETED
Registry status
108 participants
Enrollment target

Study Summary

To evaluate the performance of pachymetry function

Primary Outcome

thickness of the cornea

Interventions

  • DEVICE Pachymeter

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-01-09
Est. Completion 2025-01-28
Topcon Corporation

8 total trials

What the finished NCT06733428 record still lists

NCT06733428 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Pachymeter is the first listed.

NCT06733428 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06733428 about?

NCT06733428 is a clinical study titled "Agreement and Precision Study". To evaluate the performance of pachymetry function

What is the current status of trial NCT06733428?

This trial is currently completed. The enrollment target is 108 participants. The study started on 2025-01-09. Estimated completion is 2025-01-28.

What interventions are being tested in trial NCT06733428?

The interventions under investigation include: Pachymeter (DEVICE).

Who is sponsoring clinical trial NCT06733428?

This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06733428, the US trial registry maintained by the National Library of Medicine. NCT06733428 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.